Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.
about
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren’s SyndromeMALDI MS imaging as a powerful tool for investigating synovial tissue.Serum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study.Understanding Haemophilus parasuis infection in porcine spleen through a transcriptomics approach.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases.Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromesAcute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties.Calprotectin and platelet aggregation in patients with stable coronary artery diseaseDecreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.Profilin 1 is a potential biomarker for bladder cancer aggressivenessThe proteomics big challenge for biomarkers and new drug-targets discovery.Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritisBiomarkers of inflammation and innate immunity in atrophic nonunion fracture.Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.Proteomics focusing on immune markers in psoriatic arthritis.Lessons from the proteomic study of osteoarthritis.Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.Synovial fluid proteome in rheumatoid arthritis.Calprotectin in rheumatic diseases.High-density lipoprotein proteome dynamics in human endotoxemia.Different expression of S100A8 in malignant and benign gallbladder diseases.Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate.Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis.Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum
P2860
Q24620157-0ABADB53-ACAD-493F-87DA-6852EE41EE0BQ30460140-73301851-9DF9-4C1D-B1EF-BA0B0D468B48Q30481097-CFE5BB4D-9369-40EE-99B5-8C2B70F0ED99Q33406024-64E4EF3F-184E-4F80-BF46-B662A720757CQ33520447-A317C17C-B6E8-4753-B528-9087731D9973Q33526530-B34BBE36-E977-4023-9A92-7A200631D922Q34083843-D9F82C37-0E35-46F9-B7A1-046D09DA2367Q34776878-210AAA32-C4E0-4079-9549-D46C859FFE87Q35603084-3FEA9227-7AD1-4DEB-8E4F-B0B14165D629Q35617658-94EBCA9D-D5DB-4F4D-BED2-D250BD8C65C8Q35878733-65B99EA9-C7E9-4C07-8398-9F0AEC9D41DAQ36432402-DD24C77E-33F4-4BDD-902A-C73C6DD6CD9DQ37206919-06C23E11-8044-4852-B129-1E04BA4C8CE9Q37233069-E3609FEE-E797-4585-A45E-62BBA6C71791Q37584844-4E5ED288-4E39-47B1-A133-6F7CC3A8A634Q38230695-A2D6C36B-724E-4640-91F9-D5E589F4EED3Q38543664-6AB1BBDD-67AA-4AA2-B6D1-D9EEAAF8C26BQ38797638-B16BE5DA-2D36-4A8C-A314-69BF45440C1CQ38856510-A8D6215E-0AF2-432B-AB0E-2C98959C837DQ39022858-50AA2402-D762-41B1-8C51-86A4AE5C5937Q42848291-423CDAF3-D19B-48F1-8F6E-426A3C986A2DQ43906599-3EF411E6-9937-4828-8F4D-31CDFAFCCFCAQ47253535-2FC33241-A6FC-44E5-B297-C21F8C1756B9Q47306233-1534FD3D-DAFD-427C-B7DB-0499B16B8E2CQ50210105-37F5BA87-E84E-4E42-947F-2AD2E916E698Q51046090-31920448-8360-417A-8435-B0B4B29105EEQ53212565-8BA497D1-B15E-4704-A386-3FFB7D0FB7A1Q57623469-AE92D903-4D3E-4D43-96F8-A21555296519
P2860
Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@ast
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@en
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@nl
type
label
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@ast
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@en
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@nl
prefLabel
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@ast
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@en
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@nl
P2093
P50
P1433
P1476
Monomeric calgranulins measure ...... SA as biomarkers in arthritis.
@en
P2093
Clio Ribbens
Dominique de Seny
Edouard Louis
Jean-Paul Chapelle
Laurence Lutteri
Louis Wehenkel
Marie-Paule Merville
Michel Malaise
Raphaël Marée
P304
P356
10.1373/CLINCHEM.2007.099549
P407
P577
2008-04-24T00:00:00Z